vimarsana.com
Home
Live Updates
Ocugen Shares Rise 9% After OCU500 Inclusion in NIAID Trial : vimarsana.com
Ocugen Shares Rise 9% After OCU500 Inclusion in NIAID Trial : vimarsana.com
Ocugen Shares Rise 9% After OCU500 Inclusion in NIAID Trial
By Chris Wack Ocugen shares were up 9% at 45 cents after the company said the National Institute of Allergy and Infectious Diseases, a part of the National...
Related Keywords
Chris Wack ,
National Institutes Of Health ,
National Institute Of Allergy ,
National Institute ,
Infectious Diseases ,
National Institutes ,
Article Normal ,
Biotechnology Services ,
Pharmaceuticals ,
Vaccines ,
Healthcare Life Sciences ,
Specialized Drugs Medications ,
Financial Performance ,
Share Price Movement Disruptions ,
New Products Services ,
Research Development ,
Corporate Industrial News ,
Products Services ,
New Product Service Testing ,
Political General News ,
Health ,
Immunizations ,
Medical Treatments Procedures ,
Equity Markets ,
Commodity Financial Market News ,
Content Types ,
Factiva Filters ,
C Amp Ampe Exclusion Filter ,
C Amp Ampe Industry News Filter ,
Synd ,
Ocugen ,
Ocgn ,
Share Price Movement ,
Disruptions ,
New Products ,
Services ,
Research ,
Development ,
Corporate ,
Industrial News ,
Products ,
New Product ,
Service Testing ,
Political ,
General News ,
Medical Treatments ,
Procedures ,
Commodity ,
Financial Market News ,
Healthcare ,
Life Sciences ,
Specialized Drugs ,
Medications ,